Chapter 1 : First Light

Threshold Protocol - ICU Canon Description
"Threshold Protocol" is a covert contingency measure embedded within the Phase II Nanocell Trial program, developed under the oversight of Dr. Helena Vos and select military-contracted biotech entities. It is not officially acknowledged in any public documentation.

At its core, the Threshold Protocol is a failsafe system designed to monitor, regulate, and potentially neutralize individuals exhibiting abnormal or emergent behaviors due to their nanocell augmentation-especially if those behaviors exceed predicted safety, ethical, or controllability thresholds.